Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06723197

Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication

Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication: a Multicentre, Randomised, Controlled Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
330 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The study aimed to compare the efficacy and safety of dual and quadruple regimens with different durations (7-day, 10-day, 14-day) for the eradication of Helicobacter pylori. Subjects were randomized to receive the intervention and were reviewed by 13C-urea breath test after 6 weeks. The eradication rates, adverse reaction rates and patient adherence were calculated.

Conditions

Interventions

TypeNameDescription
DRUGvonoprazan+amoxicillinDrug combinations for dual regimens:vonoprazan+amoxicillin
OTHERDuration of eradication regimen: 7-dayDuration of eradication regimen: 7-day
DRUGvonoprazan+amoxicillin+tetracycline+bismuthDrug combinations for quadruple regimens: vonoprazan+amoxicillin+tetracycline+bismuth
OTHERDuration of eradication regimen: 10-dayDuration of eradication regimen: 10-day
OTHERDuration of eradication regimen: 14-dayDuration of eradication regimen: 14-day

Timeline

Start date
2024-12-10
Primary completion
2025-10-01
Completion
2025-11-30
First posted
2024-12-09
Last updated
2024-12-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06723197. Inclusion in this directory is not an endorsement.